The HFSA Heart Failure Seminars, launched in 2022, are 1 ½ hour virtual seminars in which HFSA brings together experts in the field to provide an update on a key topic. During the live virtual seminar, experts present information relevant to the entire HF care team with live Q&A taking place throughout the seminar. The seminar is then offered OnDemand in the HFSA Learning Center for attendees to access on their own schedule.
Heart Failure Seminars Currently Available
Upcoming Seminars
HFSA Heart Failure Seminar: What You Need to Know STAT! HF Stats
Thursday, December 19, 2024
5:00 PM – 6:30 PM ET | Virtual Livestream; OnDemand to follow
HFSA Heart Failure Seminar: From Mechanisms to Implementation
Thursday, January 23, 2024
5:00 PM – 6:30 PM ET | Virtual Livestream; OnDemand to follow
Stay tuned for more information!
OnDemand
Focus on Cardiogenic Shock
Price
- Member: FREE
- Non-Member: $59
Credits
- 1.5 CME Credits
- 1.5 CNE Credits
- 1.5 CPE Credits
Full Details
Join us for a heart failure seminar on cardiogenic shock. The seminar will delve into the definition, epidemiology, and phenotypes of cardiogenic shock, providing a foundational understanding of its various manifestations and prevalence. Attendees will also gain insights into the latest advancements in medical therapy and explore mechanical circulatory support options and the pivotal role of the care team.
Focus on Novel and Emerging Myocarditides: Recognition and Management
Price
- Member: FREE
- Non-Member: $59
Credits
- 1.5 CME Credits
- 1.5 CNE Credits
- 1.5 CPE Credits
Full Details
Join us for the 2024 HFSA HF Seminar Focus on Novel and Emerging Myocarditides, featuring expert presentations on critical topics in epidemiology, recognition, and management. This seminar brings together leading experts to delve into the latest advancements and practical insights essential for healthcare professionals at the forefront of cardiac care.
Focus on Cognitive Impairment in Heart Failure
Price
- Member: FREE
- Non-Member: FREE
Credits
- 1 CME Credits
- 1 CNE Credits
- 1 CPE Credits
Full Details
Cognitive impairment is prevalent in patients living with heart failure and was recently shown to negatively impact functional abilities, life expectancy, medication management and patient self-care. Clinicians have a responsibility to recognize and address cognitive impairment as an integral component of personalized care for patients with heart failure (HF). The upcoming HFSA Heart Failure Seminar: Focus on Cognitive Impairment in Heart Failure will feature co-authors Eiran Gorodeski, MD, MPH, FHFSA and Parag Goyal, MD, MSc, FHFSA as they identify key takeaways from the Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement. They will later be joined by co-authors Robert DiDomenico, PharmD, FHFSA and Connie White-Williams, PhD, RN, for an open discussion and Q&A session with the attending audience.
Updates in Advanced Heart Failure
Price
- Member: FREE
- Non-Member: $59.00
Credits
- 1.5 CME Credits
- 1.5 CNE Credits
- 1.5 CPE Credits
Full Details
The HFSA Heart Failure Seminar: Updates in Advanced Heart Failure is part of the HFSA’s ongoing Focus On seminar series which brings together healthcare providers (HCPs). This virtual seminar features a multidisciplinary panel of HF experts who are presenting a case-based program that is designed to provide the most current information on the management of patients with right ventricular failure; left ventricular assist devices; and emerging strategies for donation after circulatory death.
The Heart Failure Society of America acknowledges Abbott for providing an independent educational grant to support the HFSA Heart Failure Seminar: Updates in Advanced Heart Failure.
Update on GDMT, Leap Into GDMT, Tips and Tricks
Price
- Member: FREE
- Non-Member: $59.00
Credits
- 1.5 CME Credits
- 1.5 CNE Credits
- 1.5 CPE Credits
Full Details
The HFSA Heart Failure Focus on Seminar: Update on GDMT, Leap Into GDMT, Tips and Tricks, provides the most current information on the utilization of GDMT treatments for the management of patients with HF. It features a multidisciplinary panel of HF experts presenting case-based examples on topics including new and current recommendations, specific therapies, tailoring patient treatments, strategies to optimize and maintain dosing, and the impact of GDMT on HF patient outcomes.
The Heart Failure Society of America acknowledges acknowledges Boehringer Ingelheim and Eli Lilly and Company for providing an independent educational grant to support the HFSA Heart Failure Seminar: Update on GDMT, Leap Into GDMT, Tips and Tricks.
Focus on Iron Deficiency
Price
- Member: FREE
- Non-Member: $59.00
Credits
- 1.0 CME Credits
Full Details
The HFSA Heart Failure Focus on Seminar: Focus on Iron Deficiency, Ironing Out Iron Deficiencies is part of the HFSA’s ongoing Focus On seminar series which brings together healthcare providers (HCPs), including researchers, cardiologists, interventional cardiologists, primary care physicians, cardiac surgeons, internists, nurse practitioners, physician assistants, nurses, pharmacists, and other health care providers who care for patients with ID. This case-based program is being developed by practicing clinicians and is designed to provide the most current information on the pathophysiology, diagnosis, and management of HF patients with ID. After the live program, a recorded enduring version will be available for 1 year via the HFSA Learning Management System.
The Heart Failure Society of America acknowledges American Regent for providing an independent educational grant to support Heart Failure Seminar: Focus on Iron Deficiency, Ironing Out Iron Deficiencies.
Focus on Hypertrophic Cardiomyopathy
Price
- Member: FREE
- Non-Member: $59.00
Credits
- 1.5 CME Credits
Full Details
Hypertrophic cardiomyopathy (HCM) is estimated to affect some 700,000 Americans. Treatment usually includes the use of non-vasodilating beta-blockers followed by non-dihydropyridine calcium channel blockers if these therapies are not effective. Since the release of the most recent guidelines, mavacamten has been approved, and clinical trial data on emerging therapies including aficamten, ranolazine, and evolving gene therapies have been published. In our commitment to providing education that enhances clinical skills and improves patient outcomes, HFSA has identified a need for education in the selection and utilization of current and emerging therapies for HCM.
The HFSA Heart Failure Seminar: Focus on Hypertrophic Cardiomyopathy (HCM) is part of the educational seminar series, featuring a multidisciplinary panel of experts presenting a case-based program that is designed to provide the most current information on the genetics, pathophysiology, diagnosis, clinical trial data, and optimal use of current and emerging treatment options for the management of patients with HCM.
The Heart Failure Society of America acknowledges Bristol Myers Squibb and Cytokinetics for providing an independent educational grant to support HFSA Heart Failure Seminar: Focus on Hypertrophic Cardiomyopathy (HCM)
2025 HFSA Heart Failure Seminars Planned*:
- Pulmonary Hypertension and RVF
- Assessment of HF Patients for Advanced HF Therapies
- EP and Vascular Devices to Improve HF Outcomes
- Cardio-Oncology
- Palliative Care in Advanced HF
*Subject to change